BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17600378)

  • 1. Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: a meta-analysis.
    Latiano A; Palmieri O; Valvano MR; Bossa F; Latiano T; Corritore G; DeSanto E; Andriulli A; Annese V
    Inflamm Bowel Dis; 2007 Oct; 13(10):1212-9. PubMed ID: 17600378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
    Bank S; Skytt Andersen P; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Jürgen Hoffmann H; Kragh Thomsen M; Ostergaard Thomsen V; Frydenberg M; Andersen Nexø B; Sode J; Vogel U; Andersen V
    PLoS One; 2014; 9(6):e98815. PubMed ID: 24971461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PTPN22 C1858T (R620W) functional polymorphism in inflammatory bowel disease.
    Zaid Y; Senhaji N; Bakhtaoui FZ; Serrano A; Serbati N; Karkouri M; Badre W; Oudghiri M; Martin J; Nadifi S
    BMC Res Notes; 2018 Nov; 11(1):783. PubMed ID: 30384859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort.
    Spalinger MR; Zeitz J; Biedermann L; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
    PLoS One; 2016; 11(7):e0160215. PubMed ID: 27467733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease.
    Senhaji N; Nadifi S; Zaid Y; Serrano A; Rodriguez DAL; Serbati N; Karkouri M; Badre W; Martín J
    World J Gastroenterol; 2017 Dec; 23(47):8300-8307. PubMed ID: 29307990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
    Glas J; Török HP; Tonenchi L; Müller-Myhsok B; Mussack T; Wetzke M; Klein W; Epplen JT; Griga T; Schiemann U; Lohse P; Seiderer J; Schnitzler F; Brand S; Ochsenkühn T; Folwaczny M; Folwaczny C
    Inflamm Bowel Dis; 2006 Jul; 12(7):606-11. PubMed ID: 16804398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients.
    Szamosi T; Lakatos PL; ; Szilvasi A; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szabo O; Satori A; Tulassay Z; Miheller P; Horvath HC; Papp J; Tordai A; Andrikovics H
    Dig Dis Sci; 2009 Feb; 54(2):351-9. PubMed ID: 18716880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease.
    Ebrahimi Daryani N; Saghazadeh A; Moossavi S; Sadr M; Shahkarami S; Soltani S; Farhadi E; Rezaei N
    Immunol Invest; 2017 Oct; 46(7):714-729. PubMed ID: 28872970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.
    Ferraris A; Torres B; Knafelz D; Barabino A; Lionetti P; de Angelis GL; Iacono G; Papadatou B; D'Amato G; Di Ciommo V; Dallapiccola B; Castro M
    Inflamm Bowel Dis; 2006 May; 12(5):355-61. PubMed ID: 16670523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs.
    Hradsky O; Lenicek M; Dusatkova P; Bronsky J; Nevoral J; Valtrova V; Kotalova R; Szitanyi P; Petro R; Starzykova V; Bortlik M; Vitek L; Lukas M; Cinek O
    Tissue Antigens; 2008 Jun; 71(6):538-47. PubMed ID: 18489434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status.
    Crawford NP; Colliver DW; Eichenberger MR; Funke AA; Kolodko V; Cobbs GA; Petras RE; Galandiuk S
    Dig Dis Sci; 2007 Oct; 52(10):2716-24. PubMed ID: 17404888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis.
    Alizadeh BZ; Valdigem G; Coenen MJ; Zhernakova A; Franke B; Monsuur A; van Riel PL; Barrera P; Radstake TR; Roep BO; Wijmenga C; Koeleman BP
    Hum Mol Genet; 2007 Nov; 16(21):2552-9. PubMed ID: 17652100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of IBD5 locus to clinical features of IBD patients.
    Latiano A; Palmieri O; Valvano RM; D'Incà R; Vecchi M; Ferraris A; Sturniolo GC; Spina L; Lombardi G; Dallapiccola B; Andriulli A; Devoto M; Annese V
    Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis.
    Diaz-Gallo LM; Espino-Paisán L; Fransen K; Gómez-García M; van Sommeren S; Cardeña C; Rodrigo L; Mendoza JL; Taxonera C; Nieto A; Alcain G; Cueto I; López-Nevot MA; Bottini N; Barclay ML; Crusius JB; van Bodegraven AA; Wijmenga C; Ponsioen CY; Gearry RB; Roberts RL; Weersma RK; Urcelay E; Merriman TR; Alizadeh BZ; Martin J
    Inflamm Bowel Dis; 2011 Nov; 17(11):2287-94. PubMed ID: 21287672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease.
    Karban A; Hartman C; Eliakim R; Waterman M; Nesher S; Barnett-Griness O; Shamir R
    Dig Dis Sci; 2007 Oct; 52(10):2707-15. PubMed ID: 17436100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study.
    Onnie CM; Fisher SA; Pattni R; Sanderson J; Forbes A; Lewis CM; Mathew CG
    Inflamm Bowel Dis; 2006 Apr; 12(4):263-71. PubMed ID: 16633048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis.
    Sfar I; Dhaouadi T; Habibi I; Abdelmoula L; Makhlouf M; Ben Romdhane T; Jendoubi-Ayed S; Aouadi H; Ben Abdallah T; Ayed K; Zouari R; Lakhoua-Gorgi Y
    Arch Inst Pasteur Tunis; 2009; 86(1-4):51-62. PubMed ID: 20707220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease.
    Martín MC; Oliver J; Urcelay E; Orozco G; Gómez-Garcia M; López-Nevot MA; Piñero A; Brieva JA; de la Concha EG; Nieto A; Martín J
    Tissue Antigens; 2005 Oct; 66(4):314-7. PubMed ID: 16185327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.